CLINICAL TRIAL

Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: ClinicalTrials.gov
Date: 2023-05-19
Source: ClinicalTrials.gov
DOI: Unavailable
PubMed: Unavailable

Authors

University of Wisconsin Madison

Watch author

Derived topics and classifications

psilocybin Depression Addiction Clinical Trial Healthy Volunteers Safety Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of PsilocybinClinicalTrials.gov · 2026-07-29 Does Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled TrialClinicalTrials.gov · 2026-05-07 Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot PhaseClinicalTrials.gov · 2025-05-16 Safety for Home Administration of Microdose Psilocybin UseClinicalTrials.gov · 2026-08-14 Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding StudyClinicalTrials.gov · 2023-03-20 Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-samplingClinicalTrials.gov · 2026-06-05 The Effects of Psilocybin on Shared Experience in Film ProcessingClinicalTrials.gov · 2024-09-27 Consciousness and Psilocybin Effects on Well-Being: The CoPEWell StudyClinicalTrials.gov · 2026-07-02